"AB City" is the parent company of two commercially and socially significant joint stock companies: AS "Repharm" and AS "Olpha". The conglomerate includes healthcare, pharmaceutical retail and wholesale, production companies and laboratory test service providers operating in the Baltic region with a total annual turnover of over EUR 500 million.
People and health are the focus for the businesses and brands represented by "AB City", producing medicines at "Olpha", providing services at "Mēness aptieka pharmacies", "Veselības centru apvienība" medical institutions, branches of "Centrālā laboratorija", the wholesaler "Recipe Plus" as well as plant-based medicines at "Rīgas Farmaceitiskā fabrika".

"AB City" group companies actively participate in supporting areas important to society and the economy, contributing to education, science, sports, culture, and healthcare. We donate and promote initiatives that improve mental health support, increase accessibility of services for patients, foster an active and healthy lifestyle, and enhance the qualifications of doctors and pharmacists. "AB City" companies have also created a special support program for teachers, awarding scholarships to new or aspiring teachers of chemistry, biology, and mathematics. We also pay special attention to supporting Ukraine. In recent years, "AB City" group companies have provided support through donations totaling more than 8.3 million euros, not including other forms of support.
We invest in society, building a sustainable and healthy future!
We believe that affordable health care means healthier society and happier people.
SEB Group has granted a EUR 140 million long-term loan to Latvian healthcare and pharmaceutical group AS “AB City” to support the implementation of its development projects.
The campaign “Your silence is not strength!” organised by Olpha, Centrālā laboratorija, Mēness aptieka and Veselības centru apvienība has concluded.
Over eight years, Veselības centru apvienība has invested more than one million euros in its program for young doctors.